Specify Company / Ticker to Get the Summary
Dividend History PMVP
Dividend Analytics PMVP
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Pmv Pharmaceuticals Inc
PMVPPMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is rezatapopt, an orally available small molecule that potently and selectively correct p53 misfolding caused by p53 mutation, Y220C, while sparing wild-type p53. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey. Address: 400 Alexander Park Drive, Princeton, NJ, United States, 08540
Analytics
WallStreet Target Price
8.75 USDP/E Ratio
–Dividend Yield
–Financials PMVP
Results | 2019 | Dynamics |